new york, new york • the waldorf=astoria - imedex, ?· the new york presbyterian hospital new...

Download New York, New York • The Waldorf=Astoria - Imedex, ?· The New York Presbyterian Hospital New York,…

Post on 13-Feb-2019

212 views

Category:

Documents

0 download

Embed Size (px)

TRANSCRIPT

P r o g r a m C h a i r sC h a i r

Morton Coleman, MDCenter for Lymphoma and Myeloma

Weill Cornell Medical College The New York Presbyterian Hospital

New York, New York

C o - C h a i r, L y m p h o m a S e s s i o nJohn P. Leonard, MD

Center for Lymphoma and Myeloma Weill Cornell Medical College

The New York Presbyterian Hospital New York, New York

C o - C h a i r, My e l o m a S e s s i o nRuben Niesvizky, MD

Center for Lymphoma and Myeloma Weill Cornell Medical College

The New York Presbyterian Hospital New York, New York

C o - C h a i r, L e u k e m i a S e s s i o nRichard R. Furman, MD

Center for Lymphoma and Myeloma Weill Cornell Medical College

The New York Presbyterian Hospital New York, New York

W W W . I M E D E X . C O M

October 22-24, 2009 I New York, New York The Waldorf=Astoria

2nd Announcement

October 16-18, 2008 New York, New York The Waldorf=Astoria

A comprehensive forum presenting the most recent developments in lymphocytic and plasma cell neoplasms

D ear C o l l e a g u e ,It is our pleasure to invite you to join us at Lymphoma & Myeloma 2009: An International Congress on Hematologic Malignancies. This falls Congress, October 22-24, 2009 at The Waldorf=Astoria in New York, New York, promises to be our most exciting and interactive meeting yet!

Since its inception in 2000, this Congress has grown to nearly 800 attendees and has become the premier forum for discussion on the latest advances in lymphoma and myeloma. Using a dynamic approach, featuring clinical controversies, debates, and examinations of current treatment regimens, attendees will receive a thorough understanding of the evolution of thought and therapy of lymphoma and myeloma, as well as any significant developments which may lead to improved results.

Guided by the expertise of the leaders in the fields of molecular biology, pathology, immunology, and translational and clinical research, this Congress will provide for a stimulating and interactive forum for attendees from all relevant medical specialties.

Allowing attendees the benefit of visiting New York City during one of the most beautiful times of year, this Congress will be the perfect chance for you to get away and enjoy a weekend of learning in the capital city of the world.

We cordially welcome you to our fair city and promise to reward you with an exciting, informative Congress!

Sincerely,

Morton Coleman, MD, Chair

John P. Leonard, MD, Co-Chair, Lymphoma Session

Ruben Niesvizky, MD, Co-Chair, Myeloma Session

Richard R. Furman, MD, Co-Chair, Leukemia Session

October 22-24, 2009 I New York, New York I The Waldorf=Astoria

C o n g re s s O rg a n i z e r

Dark Blue C100, M55, Y0, K55

Light Blue C29, M12, Y0, K0

Orange C0, M66, Y100, K0

4325 Alexander Drive Alpharetta, Georgia 30022-3740, USA Tel.: +1 (770) 751 7332 Fax: +1 (770) 751 7334 Email: meetings@imedex.com www.imedex.com

DiscussinsightsintothebiologyofCLL

Discussevidenced-basedapproachestotherapy in CLL in both the frontline and relapsed setting

Reviewexperimentalandrecentlyapproved agents in CLL

Reviewthemostuptodateclinicaltrialdata in lymphoplasmocytic disorders

DiscussthenewWHOclassification of lymphoma

Commentontheevolutionandfutureoftreatment for Hodgkins disease

Reviewtheoptimalfrontlinestrategyforpatients with peripheral T cell lymphoma

Discussprogressmadeincutaneous T cell lymphoma

Debatetheaggressivetreatmentofmantlecell lymphoma

Improvepreventionandtreatmentofcentral nervous system lymphoma

Commentontheroleofepigenetictargeting of large cell lymphoma

Utilizeprognosticfactorstooptimizetreatment of low grade lymphoma

Reviewtreatmentoflymphomasoftheeye

Discussutilityandsafetyofnovelagentsinlow grade lymphoma

DebatetheroleofPETscansinHodgkinsand NHL

Reviewupdatesinmyelomabiology,includingcelltrafficking,mobilizationandtargeting the cell cycle

Reviewtheevaluationofminimalresidualdisease in myeloma as well as the IMW consensus on response criteria

Discussthecurrentstateoftheartintargeted therapy for myeloma

Reviewevidence-basedtreatmentoptionsfor poor risk and non-transplant eligible patients in the frontline

Discussevidence-basedtreatmentoptionsfor consolidation in patients with good prognostic indicators

Reviewnovelcombination therapies for the treatment of relapsed/refractory myeloma

Reviewhighlightsfromthe2009International Myeloma Workshop

C o n t i n u i n g M e d i c a l E d u ca t i o nCME Statement

Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to

provide continuing medical education for physicians.

Imedex, LLC designates this educational activity for a maximum 18.5 of AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

W h o S h o u l d A tte n dThis educational activity is specifically designed for hematologists, medical oncologists, transplant oncologists, radiation oncologists and other physicians, physicians-in-training, and healthcare professionals (nurses, pharmacists) involved and/or interested in lymphoma, myeloma and related plasma cell disorders and their management.

O b j e c t i v e sAfter attending this Congress, participants should be able to:

James R. Berenson, MD Institute for Myeloma and Bone Cancer Research West Hollywood, California

Steven Bernstein, MD University of Rochester Medical Center Rochester, New York

Joan Blad, MD University of Barcelona Hospital Clinic Barcelona, Spain

Arthur R. Bradwell, MD University of Birmingham Birmingham, United Kingdom

John C. Byrd, MD Ohio State University Columbus, Ohio

Asher Chanan-Khan, MD Roswell Park Cancer Institute Buffalo, New York

Selina Chen-Kiang, PhD Weill Medical College of Cornell University New York, New York

Bruce D. Cheson, MD Georgetown University Hospital Washington, District of Columbia

Bertrand Coiffier, MD Hospices Civils de Lyon Lyon, France

Morton, Coleman, MD Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Raymond L. Comenzo, MD Tufts University Medical Center Boston, Massachusetts

Claire Dearden, BSc, M.D., FRCP, FPCPathRoyal Marsden Hospital Sutton, United Kingdom

Volker Diehl, MD University Hospital of Cologne Cologne, Germany

Angela Dispenzieri, MD Mayo Clinic College of Medicine Rochester, Minnesota

Rebecca Elstrom, MD Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Scott Ely, MD, MPH Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Rafael Fonseca, MD Mayo Clinic Scottsdale,Arizona

Richard R. Furman, MD Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Randy D. Gascoyne, MD British Columbia Cancer Agency Vancouver, British Columbia, Canada

Philip R. Greipp, MD Mayo Clinic Rochester, Minnesota

Thomas Habermann, MD Mayo Clinic Rochester, Minnesota

Jean-Luc Harousseau, MD Hoteldieu Hospital Nantes, France

Sandra J. Horning, MD Stanford University Medical Center Stanford, California

Steven Horwitz, MD Memorial Sloan-Kettering Cancer Center New York, New York

Carol Ann Huff, MDJohns Hopkins University Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland

Martin Hutchings, MD Copenhagen University Hospital Copenhagen, Denmark

Sundar Jagannath, MD St. Vincents Comprehensive Cancer Center New York, New York

Brad Kahl, MD University of Wisconsin Carbone Comprehensive Cancer Center Madison, Wisconsin

Neil Kaye, MD Mayo Clinic Rochester, Minnesota

Eva Kimby, MD, PhD Karolinska Institute at Huddinge University Hospital Stockholm, Sweden

Suzanne Lentzsch, MD, PhD University of Pittsburgh Medical Center Pittsburgh, Pennsylvania

John P. Leonard, MD Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Sagar Lonial, MD Emory University Atlanta, Georgia

Tomer Mark, MD Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Peter Martin, MD Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Peter McLaughlin, MD University of Texas M. D. Anderson Cancer Center Houston, Texas

Fa c u lt y

October 22-24, 2009 I New York, New York I The Waldorf=Astoria

C o rp o ra te S u p p o rtThe following companies have provided an educational grant in support of this Congress:

Ari Melnick, MD Albert Einstein College of Medicine Bronx, New York

Ruben Niesvizky, MD Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Antonio Palumbo, MD University of Torino Torino, Italy

Roger Pearse, MD Center for Lymphoma and Myeloma Weill Cornell Medical College The New York Presbyterian Hospital New York, New York

Kanti Rai, MD Long Island Jewish Medical Center Albert Einstein College of Medicine New Hyde Park, New York

S. Vincent Rajkumar, MD Mayo Clinic Rochester, Minnesota

Steven Rosen, MD Robert H. Lurie Comprehensive

Recommended

View more >